EGFR and non-small cell lung carcinoma: Eleven stage I NSCLC patients rejected surgery and chose radiotherapy, whereas, the remaining 6 stage IV NSCLC patients were positive for EGFR mutations and showed new brain metastasis, suggesting failure of tyrosine kinase inhibitor (TKI) treatment.